Transfusion Requirements in Critically Ill Oncologic Patient
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Paulo G. Hoff, MD, PhD
ICESP - HCFMUSP
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Instituto Do Cancer Do Estado de Sao Paulo - Faculdade de Medicina Da Universidade de Sao Paulo
São Paulo, São Paulo, Brazil
Fabricio S. Bergamin, MDLudhmila A. Hajjar, MD, PhDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2012
- Primary completion
- 30 Jun 2013
- Completion
- 30 Jun 2013
- Last update posted
- 6 Nov 2012
- Registered enrollment
- 300
- Registry id
- NCT01648946
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.